Lupin Limited, a global pharmaceutical company, has announced the expansion of its Humrahi Diabetes Support Program to include heart health. This initiative aims to provide comprehensive support to patients managing diabetes and cardiovascular diseases.
Initially this launched Humrahi program has been camouflaging in empowering patients to take control of their diabetes management. The program offers personalized guidance, educational resources, and community support to facilitate better disease management. With the expansion, Humrahi will now address the critical link between diabetes and heart health, providing holistic care to patients.
Key Features of Humrahi's Expanded Program:
Personalized coaching and counseling for diabetes and heart health management
Access to expert advice from cardiologists, endocrinologists, and dietitians
Educational resources and workshops on diabetes-heart health connection
Medication adherence tracking and reminders
Community support through online forums and support groups
The expansion is timely, considering the alarming rise of cardiovascular diseases among diabetes patients in India. According to the International Diabetes Federation, people with diabetes are two to three times more likely to develop cardiovascular diseases.
The expansion of Humrahi is a significant step towards addressing the growing burden of diabetes and cardiovascular diseases in India. We aim to empower patients with knowledge, skills, and support to manage their conditions effectively
Rajeev Sibal, President – India Region Formulations, Lupin Limited
Humrahi's expanded program is available across India, accessible through the Humrahi website, mobile app, and helpline. This initiative reinforces Lupin's commitment to improving patient outcomes and enhancing quality of life.
Reference:
https://www.lupin.com/lupins-humrahi
(Input From Various Sources)
(Rehash/Neha Kamble)
